Azacytidine During Anti-tuberculosis Therapy
Condition: Tuberculosis, Pulmonary Interventions: Drug: Azacitidine Injection [Vidaza] - Phase A Group; Drug: Azacitidine Injection [Vidaza] - Phase B Group; Drug: Azacitidine Injection [Vidaza] - Phase C Group; Drug: Azacitidine Injection [Vidaza] - Phase D Group Sponsors: Andrew Dinardo; Celgene Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Tuberculosis